Entero Healthcare Solutions
add_icon

Entero Healthcare Solutions

1,062.70
+28.90
(2.80%)
Market Cap
₹4,623.69 Cr
PE Ratio
36.44
Volume
75,213.00
Day High - Low
₹1,073.30 - ₹1,022.00
52W High-Low
₹1,563.90 - ₹1,031.50
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
4,623.69 Cr
EPS
21.80
PB Ratio
2.63
Book Value
405.95
EBITDA
211.10
Dividend Yield
0.00 %
Industry
Retail
ROE Growth %
-
Debt to Equity
0.22
Analyst Rating and Forecast
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+66.67 %
+66.67 %
Hold
Hold+33.33 %
+33.33 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Entero Healthcare Solutions delivered quarterly revenue growth of 20.8% year-on-year to INR 1,571 crores with EBITDA margins expanding to 4%, while announcing plans to complete seven MedTech acquisitions worth INR 1,000 crores in proforma revenues. The company expects these acquisitions to boost gross margins by 70-90 basis points and EBITDA margins by 50-75 basis points, with 60% of M&A activity focused on the higher-margin MedTech segment.
positive
Entero Healthcare Solutions reported quarterly revenue of Rs. 1,571 crore, marking 21% year-on-year growth. The company achieved 4% EBITDA margin and 2.3% PAT margin for the quarter. Revenue growth adjusted for net margin basis impact was 23.4% year-on-year, with organic growth at 13.4%. The company improved gross margins by 29 basis points quarter-on-quarter to 10.2% and reduced net working capital days to 63 from 66 in the previous quarter. Return on capital employed increased to 13.8% from 11.5% in the last quarter. Entero announced margin-accretive acquisitions in the MedTech segment expected to generate Rs. 1,000 crore in annualized revenue. The acquisitions are projected to improve gross margins by 70-90 basis points and EBITDA margins by 50-75 basis points. The company operates 113 warehouses across 47 cities, serves 85,300 retail pharmacies and 2,800 hospitals, and maintains relationships with 2,800 healthcare product manufacturers.
positive
Entero Healthcare Solutions Limited's Board of Directors approved the promotion of Abhitesh Kumar from President-Retail Business New Initiatives to Chief Growth Officer. Kumar, who holds a B.Tech in Mechanical Engineering from BITS Pilani and a Post Graduate program in Business Management from IIM Calcutta, has over a decade of experience with 4 years in the pharmaceutical industry. The company stated that Kumar has been instrumental in scaling Entero's retail business since inception and expects this elevation to further accelerate the company's growth journey.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
808.80
#1 9,691.25
47.98
#1 6,184.70
9.18
#1 150
#1 43.41
58.68
1,062.70
#2 4,623.69
#2 36.44
#2 5,135.30
#2 30.45
#2 107
#2 40.77
44.08
47.25
92.27
#1 19.61
117.90
#1 99.16
5
-
55.85
60.01
63.20
-
9.20
-4.17
-2
-166.67
59.85
Growth Rate
Revenue Growth
30.45 %
Net Income Growth
169.85 %
Cash Flow Change
-109.97 %
ROE
150.83 %
ROCE
67.13 %
EBITDA Margin (Avg.)
28.04 %

Quarterly Financial Results

Quarterly Financials
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
832
888
901
998
994
1,043
1,111
1,312
1,367
1,346
1,410
1,576
Expenses
810
867
873
968
964
1,005
1,067
1,258
1,309
1,290
1,354
1,509
EBITDA
21
21
27
31
30
38
44
54
58
56
56
67
Operating Profit %
2 %
2 %
3 %
3 %
3 %
3 %
3 %
3 %
4 %
4 %
4 %
4 %
Depreciation
5
7
6
6
6
7
7
8
8
9
9
10
Interest
13
13
14
18
16
17
10
12
10
11
11
12
Profit Before Tax
3
1
7
7
8
14
27
35
39
37
36
45
Tax
-1
5
0
2
1
-8
7
9
10
6
6
8
Net Profit
4
-4
6
5
7
21
21
26
30
31
30
37
EPS in ₹
8.67
1.49
15.18
3.24
4.21
5.73
4.62
5.43
5.85
5.91
6.39
7.26

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
749
836
1,126
1,309
2,345
2,703
Fixed Assets
186
189
262
268
289
559
Current Assets
552
636
851
1,023
2,011
2,076
Capital Work in Progress
2
2
1
0
0
0
Investments
0
0
0
0
0
58
Other Assets
561
645
863
1,041
2,056
2,085
Total Liabilities
749
836
1,126
1,309
2,345
2,703
Current Liabilities
269
291
462
624
602
845
Non Current Liabilities
56
58
101
87
102
87
Total Equity
424
487
563
598
1,641
1,770
Reserve & Surplus
-16
-32
-62
-73
1,593
1,676
Share Capital
439
517
4
4
44
44

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-23
-11
14
-21
122
82
Investing Activities
-203
-31
-162
-49
-704
232
Operating Activities
-37
-69
-35
-45
-37
-77
Financing Activities
217
89
211
73
863
-74

Share Holding

% Holding
Sept 2023
Feb 2024
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
78.85 %
52.44 %
52.44 %
52.44 %
52.44 %
52.44 %
52.42 %
52.42 %
52.42 %
FIIs
0.00 %
0.00 %
23.30 %
23.32 %
23.82 %
22.21 %
19.92 %
17.20 %
14.67 %
DIIs
0.00 %
1.36 %
2.28 %
2.06 %
7.73 %
8.77 %
9.64 %
10.18 %
9.65 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.72 %
4.95 %
5.00 %
4.06 %
4.36 %
5.41 %
6.99 %
9.36 %
Others
21.15 %
40.48 %
17.03 %
17.18 %
11.95 %
12.23 %
12.61 %
13.20 %
13.90 %
No of Share Holders
51
58
80,864
66,400
36,767
33,172
33,159
33,338
36,334

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
28 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Aug 2024 1,245.00 1,301.20
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 1,387.70 1,477.80
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 1,372.25 1,328.65
27 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 May 2025 1,443.60 1,477.30
08 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Aug 2025 1,265.95 1,257.25
18 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
18 Sept 2025 1,158.70 1,132.30
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 1,111.35 1,089.00

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation2 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 13, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 12, 2025
Announcement under Regulation 30 (LODR)-AcquisitionNov 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementNov 12, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 12, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 12, 2025
Submission Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Nov 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Dated November 12 2025Nov 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 07, 2025
Board Meeting Intimation for Approval Of The Financial Results For The Quarter Ended September 30 2025Oct 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 03, 2025
Announcement under Regulation 30 (LODR)-Diversification / DisinvestmentSep 29, 2025
Announcement under Regulation 30 (LODR)-AcquisitionSep 29, 2025
Board Meeting Outcome for Outcome Of Board MeetingSep 29, 2025
Closure of Trading WindowSep 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 18, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 18, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 18, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 10, 2025
Announcement under Regulation 30 (LODR)-Change in Corporate Office AddressSep 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 26, 2025
General UpdatesAug 25, 2025
Business Responsibility and Sustainability Reporting (BRSR)Aug 25, 2025
Submission Of Notice Of 7Th Annual General Meeting Scheduled To Be Held On September 18 2025 At 11:30 AM (IST)Aug 25, 2025
Reg. 34 (1) Annual Report.Aug 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 21, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 19, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 08, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 08, 2025
Unaudited Financial Results For The Quarter Ended June 30 2025Aug 08, 2025
Board Meeting Outcome for Outcome Of Board MeetingAug 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 30, 2025
Board Meeting Intimation for Approval And Take On Record The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended June 30 2025.Jul 25, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 26, 2025
Closure of Trading WindowJun 25, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jun 18, 2025
Intimation For Grant Of 5900 Options Pursuant To Entero Employee Stock Option Plan 2023 To The Eligible Employees Of The Company. Jun 18, 2025

Technical Indicators

RSI(14)
Neutral
36.97
ATR(14)
Less Volatile
35.47
STOCH(9,6)
Oversold
7.75
STOCH RSI(14)
Oversold
8.57
MACD(12,26)
Bearish
-7.33
ADX(14)
Weak Trend
15.48
UO(9)
Bearish
37.86
ROC(12)
Downtrend And Accelerating
-5.07
WillR(14)
Oversold
-98.66